Haverford Trust Co Makes New Investment in Cigna Group $CI

Posted by Francis Steltz on Aug 23rd, 2026

Haverford Trust Co purchased a new stake in Cigna Group (NYSE:CI – Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 2,282 shares of the health services provider’s stock, valued at approximately $629,000.

Other institutional investors also recently made changes to their positions in the company. Wilkerson Advisory Group LLC acquired a new stake in shares of Cigna Group during the 4th quarter worth $25,000. Cedar Mountain Advisors LLC boosted its holdings in Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 68 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in Cigna Group during the second quarter valued at about $29,000. Kemnay Advisory Services Inc. purchased a new stake in Cigna Group during the fourth quarter valued at about $29,000. Finally, Prosperity Bancshares Inc purchased a new stake in Cigna Group during the fourth quarter valued at about $29,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 23,012 shares of company stock valued at $6,386,550. 0.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

CI has been the topic of a number of research reports. Wolfe Research restated an “outperform” rating and issued a $315.00 price objective on shares of Cigna Group in a report on Tuesday, June 16th. Raymond James Financial cut Cigna Group from a “strong-buy” rating to an “outperform” rating and decreased their target price for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Piper Sandler dropped their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. Morgan Stanley raised their price target on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Finally, Barclays lifted their price target on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Fifteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, Cigna Group has an average rating of “Moderate Buy” and an average price target of $339.45.

Read Our Latest Analysis on Cigna Group

Cigna Group Stock Up 0.6%

Shares of NYSE CI opened at $276.19 on Friday. The stock has a fifty day moving average price of $284.20 and a 200 day moving average price of $281.38. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The company has a market cap of $72.98 billion, a P/E ratio of 11.43, a P/E/G ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. During the same quarter in the previous year, the firm posted $7.20 earnings per share. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s payout ratio is 25.82%.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.